MedifastUS58470H1014MEDMED
Financials
Market Cap
$273.43M5Y beta
1.17EPS (TTM)
$6.201Free Float
10.64MP/E ratio (TTM)
4.03Revenue (TTM)
$897.81MEBITDA (TTM)
$94.23MFree Cashflow (TTM)
$30.11MPricing
Analyst Ratings
The price target is $25.00 and the stock is covered by 2 analysts.
Buy
0
Hold
2
Sell
0
Information
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.